ABRAXANE® (nanoparticle albumin-bound paclitaxel) is used for the treatment of patients with:

  • Metastatic breast cancer
  • Non-small cell lung cancer, in combination with another cancer medicine, carboplatin
  • Metastatic pancreatic cancer, in combination with another cancer medicine, gemcitabine

ABRAXANE Product Information (Australia)

ABRAXANE Data Sheet (New Zealand)

ABRAXANE Consumer Medicine Information

ABRAXANE Safety Data Sheet

Pancreatic Cancer - Disease Fact Sheet


NERLYNX® (neratinib) is currently under regulatory evaluation in Australia.



ICLUSIG® (ponatinib HCl) is used to treat adults with chronic myeloid leukaemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are no longer benefiting from treatment with other medicines.

ICLUSIG Product Information

ICLUSIG Consumer Medicine Information

Chronic Myeloid Leukaemia - Disease Fact Sheet


APLIDIN® (plitidepsin) is currently under regulatory evaluation in Australia.

APLIDIN Safety Data Sheet

Living with Multiple Myeloma: A Patient’s Story



GLIOLAN® (aminolevulinic acid hydrochloride) is an orally administered drug used for the visualisation of certain brain tumours (called glioblastoma multiforme) during tumour surgery.

To view a brief video of fluorescence-guided glioma surgery using GLIOLAN, click here

GLIOLAN Product Information (Australia)

GLIOLAN Data Sheet (New Zealand)

GLIOLAN Consumer Medicine Information

GLIOLAN Safety Data Sheet

GLIOLAN Neurosurgeon Training Program

Gliolan Experienced User Meeting Video

Supportive Care

Gelclair® relieves oral mucositis pain by forming a protective barrier over exposed nerves

Genomic Assays

Oncotype DX Breast Recurrence Score
The Oncotype DX® Breast Cancer Assay provides patients and their physicians with individualised information about their breast cancer to guide decisions on how to proceed with treatment.
Oncotype DX Prostate Recurrence Score
The Oncotype DX® Prostate Cancer Assay provides men with newly diagnosed, low-risk prostate cancer and their urologists, critical information to help guide decisions about treatment.